Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): Findings from the Heart and Soul Study

被引:21
|
作者
Desai, Arati S.
Bibbins-Domingo, Kirsten
Shlipak, Michael G.
Wu, Alan H. B.
Ali, Sadia
Whooley, Mary A.
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA
[2] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] San Francisco Gen Hosp, San Francisco, CA USA
[5] Vet Affairs Med Ctr, San Francisco, CA 94121 USA
[6] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
关键词
anemia; natriuretic peptide;
D O I
10.1016/j.ejheart.2007.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anaemia is associated with elevated levels of natriuretic peptides. Whether the association of anaemia with natriuretic peptides is independent of other cardiovascular risk factors is unclear. Methods: This was a cross-sectional study of 809 ambulatory patients with coronary heart disease (CHD) and no history of heart failure (HF). We evaluated the extent to which the relationship between haemoglobin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) was explained by differences in cardiovascular risk factors, inflammation, and kidney dysfunction. Results: Of the 809 participants, 189 (23%) had anaemia (haemoglobin < 13 g/dL). Haemoglobin (as a continuous variable) was inversely associated with log NT-proBNP (beta coefficient -.28, p<.0001). This association was considerably attenuated after accounting for cardiovascular risk factors, C-reactive protein, and kidney dysfunction. However, haemoglobin remained independently associated with log NT-proBNP even after adjustment for these variables (beta coefficient -.11, p=0.0003). Each 1 g/dL decrease in haemoglobin was associated with a 20% greater odds of having NT-proBNP in the highest quartile. Conclusions: The relationship between anaemia and NT-proBNP is largely explained by differences in cardiovascular risk factors, ventricular function, myocardial ischaemia, inflammation, and kidney function. Nonetheless, haemoglobin appears to be inversely associated with NT-proBNP even after adjustment for these risk factors. Published by Elsevier B.V.
引用
收藏
页码:886 / 891
页数:6
相关论文
共 50 条
  • [11] Association of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and acute kidney disease in patients undergoing coronary angiography: a cohort study
    Ling, Yihang
    He, Yibo
    Guo, Wei
    Zhang, Rongting
    Zhao, Yukun
    Yu, Sijia
    Huang, Zhidong
    Li, Qiang
    Huang, Haozhang
    Liu, Jin
    Liu, Yong
    Chen, Jiyan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (08) : 2067 - 2073
  • [12] Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
    Welsh, Paul
    Campbell, Ross T.
    Mooney, Leanne
    Kimenai, Dorien M.
    Hayward, Caroline
    Campbell, Archie
    Porteous, David
    Mills, Nicholas L.
    Lang, Ninian N.
    Petrie, Mark C.
    Januzzi, James L.
    McMurray, John J., V
    Sattar, Naveed
    CIRCULATION-HEART FAILURE, 2022, 15 (10) : E009427
  • [13] The relation between N-terminal pro-B-type natriuretic peptide and heart failure
    Balta, Sevket
    Demirkol, Sait
    Kucuk, Ugur
    Unlu, Murat
    Arslan, Zekeriya
    Celik, Turgay
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (10): : 1533 - 1533
  • [14] The N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a marker of silent coronary artery disease among asymptomatic diabetics
    Cosson, E.
    Nguyen, M. T.
    Pham, I.
    Pontet, M.
    Nitenberg, A.
    Valensi, P.
    DIABETES & METABOLISM, 2009, 35 : A7 - A7
  • [15] Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction
    Lorgis, L.
    Cottin, Y.
    Danchin, N.
    Mock, L.
    Sicard, P.
    Buffet, P.
    L'Huillier, I.
    Richard, C.
    Beer, J. C.
    Touzery, C.
    Gambert, P.
    Zeller, M.
    HEART, 2011, 97 (07) : 551 - 556
  • [16] Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA)
    Ostovaneh, Mohammad R.
    Moazzami, Kasra
    Yoneyama, Kihei
    Venkatesh, Bharath A.
    Heckbert, Susan R.
    Wu, Colin O.
    Shea, Steven
    Post, Wendy S.
    Fitzpatrick, Annette L.
    Burke, Gregory L.
    Bahrami, Hossein
    Sanchez, Otto A.
    Daniels, Lori B.
    Michos, Erin D.
    Bluemke, David A.
    Lima, Joao A. C.
    HYPERTENSION, 2020, 75 (02) : 316 - 323
  • [17] N-terminal pro-B-type natriuretic peptide and inducible ischemia in patients with coronary heart disease from the heart and soul study
    Singh, H. S.
    Bibbins-Domingo, K.
    Sadia, A.
    Whooley, M. A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 54 - 54
  • [18] Point of care with serial N-terminal pro-B-type natriuretic peptide (NT-proBNP) for heart failure in patients with acute decompensation. An invited commentary
    Sergi, Consolato M.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 26
  • [19] N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Immunoreactivity Is Reduced After 6 Years of Storage at -70 degrees C
    Wee, Tracee
    Tang, Mila
    Zrno, Ilinka
    Hamilton, Jonah
    Holmes, Daniel T.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2016, 1 (03): : 300 - 305
  • [20] Usefulness of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) as a marker for cardiotoxicity and comparison with echocardiography in paediatric carbon monoxide poisoning
    Turan, Caner
    Dogan, Eser
    Yurtseven, Ali
    Saz, Eylem Ulas
    CARDIOLOGY IN THE YOUNG, 2020, 30 (08) : 1103 - 1108